Pharma Mar, S.A. (BME:PHM)
Spain flag Spain · Delayed Price · Currency is EUR
87.95
-2.50 (-2.76%)
Oct 7, 2025, 5:35 PM CET

Pharma Mar Statistics

Total Valuation

Pharma Mar has a market cap or net worth of EUR 1.57 billion. The enterprise value is 1.49 billion.

Market Cap1.57B
Enterprise Value 1.49B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date Oct 28, 2025
Ex-Dividend Date Jun 25, 2025

Share Statistics

Pharma Mar has 17.35 million shares outstanding.

Current Share Class 17.35M
Shares Outstanding 17.35M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 11.94%
Owned by Institutions (%) 9.10%
Float 13.43M

Valuation Ratios

The trailing PE ratio is 37.36 and the forward PE ratio is 24.95.

PE Ratio 37.36
Forward PE 24.95
PS Ratio 8.29
PB Ratio 7.79
P/TBV Ratio 7.83
P/FCF Ratio 883.76
P/OCF Ratio 178.36
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.24, with an EV/FCF ratio of 840.58.

EV / Earnings 35.54
EV / Sales 7.89
EV / EBITDA 39.24
EV / EBIT 47.48
EV / FCF 840.58

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.26.

Current Ratio 2.84
Quick Ratio 2.14
Debt / Equity 0.26
Debt / EBITDA 1.35
Debt / FCF 28.94
Interest Coverage 7.69

Financial Efficiency

Return on equity (ROE) is 21.94% and return on invested capital (ROIC) is 8.30%.

Return on Equity (ROE) 21.94%
Return on Assets (ROA) 5.91%
Return on Invested Capital (ROIC) 8.30%
Return on Capital Employed (ROCE) 12.07%
Revenue Per Employee 378,534
Profits Per Employee 84,018
Employee Count500
Asset Turnover 0.57
Inventory Turnover 0.19

Taxes

Income Tax -9.13M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +94.02% in the last 52 weeks. The beta is -0.01, so Pharma Mar's price volatility has been lower than the market average.

Beta (5Y) -0.01
52-Week Price Change +94.02%
50-Day Moving Average 84.96
200-Day Moving Average 83.95
Relative Strength Index (RSI) 55.93
Average Volume (20 Days) 74,347

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Pharma Mar had revenue of EUR 189.27 million and earned 42.01 million in profits.

Revenue189.27M
Gross Profit 179.76M
Operating Income 31.44M
Pretax Income 32.88M
Net Income 42.01M
EBITDA 35.93M
EBIT 31.44M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has 128.08 million in cash and 51.40 million in debt, giving a net cash position of 76.68 million or 4.42 per share.

Cash & Cash Equivalents 128.08M
Total Debt 51.40M
Net Cash 76.68M
Net Cash Per Share 4.42
Equity (Book Value) 201.53M
Book Value Per Share n/a
Working Capital 161.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.80 million and capital expenditures -7.02 million, giving a free cash flow of 1.78 million.

Operating Cash Flow 8.80M
Capital Expenditures -7.02M
Free Cash Flow 1.78M
FCF Per Share 0.10
Full Cash Flow Statement

Margins

Gross margin is 94.98%, with operating and profit margins of 16.61% and 22.20%.

Gross Margin 94.98%
Operating Margin 16.61%
Pretax Margin 17.37%
Profit Margin 22.20%
EBITDA Margin 18.98%
EBIT Margin 16.61%
FCF Margin 0.94%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 0.88%.

Dividend Per Share 0.80
Dividend Yield 0.88%
Dividend Growth (YoY) 23.08%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield 0.86%
Earnings Yield 2.68%
FCF Yield 0.11%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.

Last Split Date Jul 22, 2020
Split Type Reverse
Split Ratio 0.0833333333

Scores

Pharma Mar has an Altman Z-Score of 7.13 and a Piotroski F-Score of 6.

Altman Z-Score 7.13
Piotroski F-Score 6